In a report released today, Vanessa Thomson from Jefferies upgraded Ansell to a Buy, with a price target of A$39.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vanessa Thomson’s rating is based on a combination of factors that highlight Ansell’s strong market position and growth potential despite potential tariff challenges. The company has demonstrated resilience by successfully negotiating previous tariff impacts and is expected to continue this trend, which could mitigate the effects of any new tariffs on US imports of healthcare PPE. Ansell’s acquisition of Kimberly-Clark PPE has significantly bolstered its market presence, especially in the US, leading to an anticipated increase in group revenue and EBIT.
Furthermore, Ansell’s current price-to-earnings ratio is considered attractive, trading below pre-acquisition levels, suggesting that the market may not fully appreciate the company’s growth prospects. The potential for sales growth and successful project execution in the coming fiscal year further supports the Buy rating. Overall, the combination of strategic acquisitions, effective tariff management, and a favorable valuation underpin Vanessa Thomson’s positive outlook on Ansell’s stock.
In another report released on October 3, TR | OpenAI – 4o also upgraded the stock to a Buy with a A$36.00 price target.